Stockscreener 앱 받기
0.00
2.62%
17.97
전일 마감가:
$17.97
열려 있는:
$0
하루 거래량:
0
Relative Volume:
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
0.00
EPS:
0.62
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+2.67%
6개월 성능:
+137.32%
1년 성능:
+6.04%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$0.00
Defiance Trillion Dollar Club Index Etf Stock (TRIL) Company Profile
명칭
Defiance Trillion Dollar Club Index Etf
전화
-
주소
-
Compare TRIL vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRIL
Defiance Trillion Dollar Club Index Etf
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.73 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
680.33 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
683.37 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
274.02 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
601.58 | 124.43B | 0 | 0 | 0 | 0.00 |
Defiance Trillion Dollar Club Index Etf Stock (TRIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-11-17 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-04-14 | 개시 | The Benchmark Company | Buy |
| 2020-10-12 | 개시 | Evercore ISI | Outperform |
| 2020-09-10 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-08-17 | 개시 | Craig Hallum | Buy |
| 2020-06-19 | 개시 | Oppenheimer | Outperform |
| 2020-05-26 | 개시 | JMP Securities | Mkt Outperform |
| 2018-04-13 | 재개 | Leerink Partners | Mkt Perform |
| 2017-07-17 | 개시 | H.C. Wainwright | Buy |
| 2016-08-03 | 개시 | Ladenburg Thalmann | Buy |
| 2015-05-15 | 개시 | Oppenheimer | Outperform |
| 2015-04-27 | 개시 | Leerink Partners | Outperform |
모두보기
Defiance Trillion Dollar Club Index Etf 주식(TRIL)의 최신 뉴스
PA Daily | Coinbase CEO denies White House will withdraw support for the CLARITY Act; Bitcoin spot ETF sees net inflows of $1.42 billion this week. - 富途牛牛
Defiance ETFs Announces Closure of Select Funds - The Manila Times
Defiance Trillion Dollar Club Index ETF (TRIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ETF Prime: Murphy on the New Faces of the ETF Boom - ETF Database
ETF Trades: What Has and Hasn’t Worked in 2025ETF Prime with Nate GeraciPodcasts - Advisor Perspectives
TRIL ETF Holdings List — BOATS:TRIL - TradingView
Defiance floats ETF tied to firms, digital assets valued above US$1 trillion - Structured Retail Products
TRIL Stock Fund Price and Chart — BOATS:TRIL - TradingView — Track All Markets
US ETF launches from 25th September to 2nd October, 2025 - ETF Express
‘$1 Trillion Club’ ETF Offers Investors Exposure to Tech Giants and Bitcoin - The Currency analytics
Defiance Trillion Dollar Club Index ETF (NASDAQ: TRIL)Share Price - intelligentinvestor.com.au
A new "Trillion Dollar" ETF based on stocks and Bitcoin has appeared in the US. - Happy Coin News
'$1T Club' ETF offers exposure to tech giants and Bitcoin - Bitget
Tron Inc. Shares Tumble 85% From June Peak Amid DAT Market Slump - Decrypt
Defiance ETFs Launches New Trillion-Dollar Assets ETF: U.S. Access to Tech Giants and Crypto-Linked Plays - Blockchain News
SEC No-Action Letter Creates Opening for More Firms to Serve as Crypto Custodians - Decrypt
Ripple CTO David Schwartz to Step Back, Remain on Board as CTO Emeritus - Decrypt
'$1 Trillion Club' ETF Gives Investors Exposure to Tech Giants—And Bitcoin - Decrypt
Defiance Launches $TRIL – The Trillion Dollar Club ETF: The New “Magnificent 7” of Global Markets - GlobeNewswire
TRIL ETF Analysis: Dividends, Returns NASDAQ:TRIL - TradingView — Track All Markets
Defiance Launches JEDI – Drone & Modern Warfare ETF: Exposure to Leading Drone and Modern Warfare Companies - GlobeNewswire
Defiance ETFs Launches QLDY, the First ETF to Pay Distributions Twice Weekly * - GlobeNewswire
Defiance’s QTUM – Quantum Computing ETFSurpasses $2 - GlobeNewswire
Sezary Syndrome Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | 4SC AG, Seagen Inc., Merck Sharp & Dohme Corp., Innate Pharma, Trillium Therapeutics, Sec - Barchart.com
Defiance ETFs Launches Leveraged + Income ETFs for AMD (AMDU) and Super Micro Computer (SMCC) - GlobeNewswire
Defiance ETFs Launches Leveraged + Income ETFs for Palantir - GlobeNewswire
Defiance Launches VIXI: Enhanced Long Volatility ETF with Leveraged Short S&P 500 Exposure - GlobeNewswire
Defiance Launches AIPO: The First ETF Focused on AI Power Infrastructure - GlobeNewswire
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – July 7-July 11, 2025 - Trackinsight
Pfizer ends Phase 1b/2 trial for final Trillium CD47 drug - Endpoints News
Defiance ETFs Unveils $MST: The First Leveraged MicroStrategy ETF that Seeks to Pay Income Weekly - GlobeNewswire
Defiance Launches $GLDY, Gold Enhanced Options Income ETF - GlobeNewswire
Defiance’s XMAG ETF Outshines S&P 500 Amid “Magnificent 7” - GlobeNewswire
Defiance ETFs' QTUM, Quantum Computing ETF, Earns 5-Star Morningstar Rating and Surpasses $1 Billion in AUM - GlobeNewswire
CD47 Antigen Inhibitors Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight - GlobeNewswire
$QTUM, Defiance Quantum Computing ETF, Surpasses $1 Billion in AUM - GlobeNewswire
Defiance Launches XMAG The First ETF Offering Exposure to the S&P 500 Excluding the “Magnificent 7” Tech Giants - GlobeNewswire
Defiance ETFs Announces Monthly Distributions on $QQQY - GlobeNewswire
GlobeNewswire by Notified - The Manila Times
Quell Therapeutics Appoints Experienced Biopharma Leader - GlobeNewswire
Genexine, EPD Biotherapeutics to merge for new protein degraders - BioWorld MedTech
Pension plans still AWOL as Canadian life-sciences venture capital firms re-up for latest funds - The Globe and Mail
Pfizer to acquire Trillium in $2.3bn deal - BioProcess International
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment - PR Newswire
Ozempic maker Novo Nordisk bulks up on weight loss drugs, buying Montreal’s Inversago for $1-billion - The Globe and Mail
Bellus shareholders approve US$2-billion takeover by GSK; deal set to close this month - The Globe and Mail
Novartis buys Chinook for US$3.2-billion, latest in string of big exits for Canadian biotechs - The Globe and Mail
GSK’s $2-billion purchase of Bellus delivers second big exit for Montreal’s Bellini family - The Globe and Mail
Jan Skvarka, former Trillium CEO, on Driving a Turnaround - Timmerman Report
Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors - citybiz
Autobahn Therapeutics raises funds to advance ABX-002 for treatment-resistant depression - BioWorld MedTech
Defiance Trillion Dollar Club Index Etf (TRIL) 재무 분석
Defiance Trillion Dollar Club Index Etf (TRIL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.23%
자본화:
|
볼륨(24시간):